Although it has been established for many years that the lymphoid lineages derived from multipotential stem cells, precursors representing intermediate stages of development between the stem cell and B and T cell restricted precursors are not well defined. We have recently identified a fetal lymphoid precursor with B cell, T cell and macrophage (B/T/MAC) potential that represents at least one intermediate stage of lymphoid development and as such a precursor that defines a novel commitment step within the hematopoietic system. The overall goals of this proposal are to take advantage of these findings to define early commitment step within the lymphoid system.
The first aim of the proposal is to further characterize the B/T/MAC precursor with respect to cell surface phenotype, growth requirements and developmental potential, including natural killer (NK) and dendritic cell potential. These experiments will enable us to define the relationship of this precursor to other lymphoid precursors that have been identified and to more precisely position it within the hematopoietic hierarchy. In the second aim, we will define the developmental origin of B/T/MAC precursor, track its fate in embryonic and fetal development. The outcome of these experiments will provide new information on the role of this precursor in fetal lymphopoiesis and in fetal thymic development.
The third aim of the proposal is the characterization of the molecular events involved in lymphoid commitment. We will focus on the identification and characterization of genes that have been isolated from a subtractive hybridization between a colony derived from a B/T/MAC precursor and a colony derived from a more restricted B/MAC precursor. The ultimate goal of this aspect of the proposal is to define genes that play a critical role in lymphoid development. Together the information obtained from these studies will provide us with a better understanding of the events involved in the commitment of hematopoietic stem cells to the lymphoid lineages. Defining these events in normal lymphoid development will ultimately provide new insights into molecular and cellular changes that can lead to the earliest stages of diseases such as immunodeficiency and leukemia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL065169-01
Application #
2906799
Study Section
Immunobiology Study Section (IMB)
Project Start
1999-09-15
Project End
2003-07-31
Budget Start
1999-09-15
Budget End
2000-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Kubo, Atsushi; Chen, Vincent; Kennedy, Marion et al. (2005) The homeobox gene HEX regulates proliferation and differentiation of hemangioblasts and endothelial cells during ES cell differentiation. Blood 105:4590-7
D'Souza, Sunita L; Elefanty, Andrew G; Keller, Gordon (2005) SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood 105:3862-70
Kouskoff, Valerie; Lacaud, Georges; Schwantz, Staci et al. (2005) Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 102:13170-5
Kubo, Atsushi; Shinozaki, Katsunori; Shannon, John M et al. (2004) Development of definitive endoderm from embryonic stem cells in culture. Development 131:1651-62
Lacaud, Georges; Kouskoff, Valerie; Trumble, Anne et al. (2004) Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells. Blood 103:886-9
Lin, Reigh-Yi; Kubo, Atsushi; Keller, Gordon M et al. (2003) Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology 144:2644-9
Fehling, Hans Jorg; Lacaud, Georges; Kubo, Atsushi et al. (2003) Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-27
Lacaud, Georges; Gore, Lia; Kennedy, Marion et al. (2002) Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100:458-66